Effectiveness of COVID-19 Vaccination against Severe Symptoms and Death Among Geriatric Inpatients: A Retrospective Cohort Study in Macao
View abstract on PubMed
Summary
This summary is machine-generated.COVID-19 vaccination reduced symptom severity in elderly hospitalized patients during the Omicron BF.7 surge. Complete vaccination significantly lowered mortality risk, emphasizing timely immunization for maximum protection.
Area Of Science
- Geriatric Medicine
- Infectious Diseases
- Public Health
Background
- COVID-19 vaccination is crucial for protecting vulnerable populations, particularly the elderly, against emerging SARS-CoV-2 variants.
- The Omicron BF.7 surge necessitated evaluating vaccine effectiveness in real-world clinical settings.
Purpose Of The Study
- To assess the impact of COVID-19 vaccination on symptom severity and mortality in hospitalized geriatric patients.
- To investigate the role of vaccination timing in mitigating severe outcomes during the Omicron BF.7 surge.
Main Methods
- Retrospective analysis of electronic health records and vaccination data from inpatients aged 60+ at Kiang Wu Hospital (December 2022 - March 2023).
- Comparison of clinical outcomes (CXR scores, MEWS scores, mortality) between vaccinated and unvaccinated groups, and between complete and incomplete vaccination statuses.
Main Results
- Vaccinated patients exhibited significantly lower mean CXR and MEWS scores, indicating reduced disease severity.
- While overall dose count showed no difference in mortality odds, complete vaccination was associated with a 54% reduction in mortality risk (p=0.026).
Conclusions
- COVID-19 vaccination demonstrates effectiveness in reducing symptom severity among hospitalized elderly patients.
- Vaccination timing is a critical factor; complete vaccination regimens significantly enhance protection against mortality, underscoring the importance of adherence to schedules.

